A randomized controlled trial of telecare and face to face consultation with CA-F17 based on the standard smoking cessation program for nicotine dependence.

A randomized controlled trial of telecare and face to face consultation with CA-F17 based on the standard smoking cessation program for nicotine dependence. - A randomized controlled trial of telecare and face to face consultation with CA-F17 based on the standard smoking cessation program for nicotine dependence.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031620

Enrollment

114

Registered

2018-03-08

Start date

2018-03-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nicotine dependence

Interventions

Intervention group:One-time dispense of CA-F17 in conjunction with 3months of Standard Treatment of Nicotine Dependence using telecommunications technology. Control group:One-time dispense of CA-F17

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases using a smartphone, diagnosed as nicotine dependent on tobacco dependence screening test who intend to quit smoking immediately

Exclusion criteria

Exclusion criteria: Cases judged difficult to participate in the trial, such as severe mental illness

Design outcomes

Primary

Measure	Time frame
9-12 week Continuous Abstinence Rate	—

Countries

Japan

Contacts

Public ContactTomoyasu Muto

CureApp, Inc. Clinical and Regulatory Affairs Department

clinreg_admin@cureapp.jp03-6231-0183

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026